Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$213K Hold
4,987
0.04% 150
2026
Q1
$240K Sell
4,987
-318
-6% -$14.8K 0.05% 147
2025
Q4
$257K Sell
5,305
-376
-7% -$18.6K 0.05% 140
2025
Q3
$268K Buy
5,681
+79
+1% +$3.81K 0.06% 143
2025
Q2
$271K Buy
5,602
+546
+11% +$27.9K 0.06% 135
2025
Q1
$280K Buy
5,056
+879
+21% +$47.6K 0.07% 134
2024
Q4
$201K Sell
4,177
-258
-6% -$13.1K 0.05% 157
2024
Q3
$256K Buy
+4,435
New +$239K 0.06% 139

Other funds holding SNY

Berkshire Bank's SNY Position: Q2 2026 in Review

Berkshire Bank held its Sanofi (SNY) position steady in Q2 2026 at 4,987 shares worth $213K. The position accounts for 0.04% of the portfolio, ranked #150.

Berkshire Bank first reported a position in SNY in Q3 2024 and has held it in 8 quarters since. The position peaked at $280K in Q1 2025. 160 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Berkshire Bank held 4,987 shares of Sanofi worth $213K as of Q2 2026.
  • Berkshire Bank left its Sanofi share count unchanged in Q2 2026.
  • Sanofi made up 0.04% of Berkshire Bank's portfolio in Q2 2026, its #150 holding.
  • Berkshire Bank first reported a position in Sanofi in Q3 2024 and has held it in 8 quarters since.
  • Berkshire Bank's Sanofi position peaked at $280K in Q1 2025.
  • 160 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Berkshire Bank's 13F filing for Q2 2026, filed 8 Jul 2026.